Advanced Search
Yu Weijlang. Evaluation of radiotherapy plus chemotherapy in the treatment of patients with stace Ⅲ adenocarcinoma of lung[J]. Cancer Research on Prevention and Treatment, 1994, 21(4): 234-235.
Citation: Yu Weijlang. Evaluation of radiotherapy plus chemotherapy in the treatment of patients with stace Ⅲ adenocarcinoma of lung[J]. Cancer Research on Prevention and Treatment, 1994, 21(4): 234-235.

Evaluation of radiotherapy plus chemotherapy in the treatment of patients with stace Ⅲ adenocarcinoma of lung

More Information
  • Between 1989 and 1992, 52 patients with stage Ⅲ adenocarcinoma of lung were treated, of them, 24_underwent radiotherapy only and 28 were treated by radiotherapy plus chemotherapy. The response rate (CR+PR) were 33.35 and 53.6% respectively (P>0.1). In patients with chemotherapy, the incidence of side effects (vomiting, nausea, Ieucopenia and thrombocytopenia) was significantly higher than those without chemotherapy (P<0.05). but no discontinuation of the treatment happened because of side effects. In patients without chemotherapy, the systemic metastase rate was higher than patients with chemotherapy (33%:18%). but no statistical differance was found. It was suggested that radiotherapy plus chemotherapy in the treatment of patients with stage Ⅲ adenocarcinoma of lung did not show better result.
  • 1. Kaasa S.,et al.Radiother Oncol,1988,11:7.
    2. Miller TP,et al.J Clin Oncol,1986,4:502.
    3. Rappe,et al.J Clin Oncol,1988,6:633.
    4. 刘广森,等.痛症,1989,8(3):205.
    5. Ganz PA,et al.Cancer,1989,63:1271.
    6. Callerinok,et al.Eur J Clin Oncol,1988,24:1834.
    7. Kaase S,et al.Cancer,1991,67:2443.
  • Related Articles

    [1]ZHENG Qingyuan, YANG Rui, WANG Lei, CHEN Zhiyuan, LIU Xiuheng. Research Progress of Deep Learning in Bladder Cancer Pathology[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 98-102. DOI: 10.3971/j.issn.1000-8578.2023.22.0704
    [2]MA Xiangtao. Paleopathology on History of Oncology[J]. Cancer Research on Prevention and Treatment, 2015, 42(03): 215-218. DOI: 10.3971/j.issn.1000-8578.2015.03.001
    [3]XU La-mei, YANG Xaio-ling. Clinical pathological analysis about pleural malignant mesothelioma[J]. Cancer Research on Prevention and Treatment, 2002, 29(01): 30-31. DOI: 10.3971/j.issn.1000-8578.116
    [4]GAO Shi-jun, YANG Xiao-ling, WU Chang-ming, et al. The Correlation of Expression of Vascular Endothelial Growth Factorand Pathology of Adenoid Cystic Carcinoma of Salivary Gland[J]. Cancer Research on Prevention and Treatment, 2001, 28(04): 276-277. DOI: 10.3971/j.issn.1000-8578.1768
    [5]CHEN Chun-mei, XIA He-shun, YIN Han-min, et al, . Pathology Study about Osteosarcoma Invaded Epiphyseal Plate and Cartilage and MVD,the Expression of VEGF.SMA.Desmin and Their Relationship[J]. Cancer Research on Prevention and Treatment, 2000, 27(06): 454-456. DOI: 10.3971/j.issn.1000-8578.1214
    [6]CHEN Chun-mei, XIA He-shun, WU Chang-ming. Pathology and Immunohistochemical Study of Mucous Malignant Melanoma[J]. Cancer Research on Prevention and Treatment, 2000, 27(05): 378-379. DOI: 10.3971/j.issn.1000-8578.2754
    [7]CHEN Chun-mei, XIA He-shun, WU Jian-Ping, . A Study on Fiberbronchoscope,Clinicopathology and Immunohistochemistry of Lung Small Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(5): 344-346.
    [8]Wang Jinghua, . Clinical and pathological study of 31 cases with gastrointestinal mucosa-associated lymphoid tissue lymphoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 475-476.
    [9]Tan De-ying, . Clinical Pathological Study of Uighur Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 1995, 22(5): 285-286.
    [10]Chang Rongchun, . CLINICAL PATHOLOGICAL ANALYSIS ON 583 CASES ILLED WITH OVARIOTUMOUS IN ZHOU SHAN AREA[J]. Cancer Research on Prevention and Treatment, 1991, 18(4): 225-226.

Catalog

    Article views (974) PDF downloads (247) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return